151 related articles for article (PubMed ID: 38730095)
1. DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
Zhang B; Xue J; Xu B; Chang J; Li X; Huang Z; Zhao H; Cai J
Sci Rep; 2024 May; 14(1):10726. PubMed ID: 38730095
[TBL] [Abstract][Full Text] [Related]
2. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
Liao R; Li DW; Du CY; Li M
J Gastrointest Surg; 2018 Oct; 22(10):1679-1687. PubMed ID: 29777455
[TBL] [Abstract][Full Text] [Related]
3. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
[TBL] [Abstract][Full Text] [Related]
4. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.
Wang Y; Sun K; Shen J; Li B; Kuang M; Cao Q; Peng S
Cancer Res Treat; 2019 Oct; 51(4):1464-1478. PubMed ID: 30913869
[TBL] [Abstract][Full Text] [Related]
5. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection.
Ke MY; Zhang M; Su Q; Wei S; Zhang J; Wang Y; Wu R; Lv Y
J Surg Res; 2018 Nov; 231():403-410. PubMed ID: 30278960
[TBL] [Abstract][Full Text] [Related]
6. Predictive nomograms based on gamma-glutamyl transpeptidase to prealbumin ratio for prognosis of hepatocellular carcinoma patients without microvascular invasion.
Ma M; Xie K; Jin T; Xu F
BMC Cancer; 2024 May; 24(1):617. PubMed ID: 38773511
[TBL] [Abstract][Full Text] [Related]
7. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
Wang ZX; Peng W; Zhang XY; Wen TF; Li C
Medicine (Baltimore); 2021 Mar; 100(11):e24476. PubMed ID: 33725934
[TBL] [Abstract][Full Text] [Related]
9. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
10. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
Li J; Tao H; Zhang E; Huang Z
Cancer Med; 2021 Jul; 10(14):4844-4854. PubMed ID: 34145988
[TBL] [Abstract][Full Text] [Related]
12. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
[TBL] [Abstract][Full Text] [Related]
13. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
[TBL] [Abstract][Full Text] [Related]
14. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
[TBL] [Abstract][Full Text] [Related]
15. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy.
Feng LH; Sun HC; Zhu XD; Liu XF; Zhang SZ; Li XL; Li Y; Tang ZY
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):681-689. PubMed ID: 33189491
[TBL] [Abstract][Full Text] [Related]
16. Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma.
Matsumoto T; Shiraki T; Niki M; Sato S; Tanaka G; Shimizu T; Yamaguchi T; Park KH; Mori S; Iso Y; Ishizuka M; Kubota K; Aoki T
Eur J Surg Oncol; 2024 Jun; 50(6):108356. PubMed ID: 38685177
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
18. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.
Qiao W; Li J; Xiong Y; Zheng J; Jin R; Hu C
J Cancer Res Clin Oncol; 2024 May; 150(5):241. PubMed ID: 38713414
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma.
Wang X; Mao M; He Z; Zhang L; Li H; Lin J; He Y; Dai S; Hu W; Liu W
Int J Biol Sci; 2019; 15(1):221-228. PubMed ID: 30662361
[TBL] [Abstract][Full Text] [Related]
20. Screening of Hepatocellular Carcinoma Patients with High Risk of Early Recurrence After Radical Hepatectomy Using a Nomogram Model Based on the γ-Glutamyl Transpeptidase-to-Albumin Ratio.
Pang S; Shi Y; Xu D; Sun Z; Chen Y; Yang Y; Zhao X; Si-Ma H; Yang N
J Gastrointest Surg; 2022 Aug; 26(8):1-9. PubMed ID: 35508683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]